The Evidence of Value® Model (EVM) is an interactive software program that calculates the value of new medical technologies, including drugs, medical devices, diagnostics and other therapeutic interventions. The EVM provides an independent and credible analysis of the cost and clinical impact of new technologies. The EVM supplies practical answers to the important questions asked by technology purchasers and users about the value of new and expensive technologies.

The Disease Incidence Model® predicts the incidence of disease for any patient population, benchmarks it against national standards and identifies outliers from a cost and disease frequency perspective. The Disease Incidence Model® goes beyond traditional projections and underwriting to pinpoint the diseases that result in medical costs, so that medical management can be optimized. It is an invaluable risk assessment and positioning tool, important adjunct to underwriting and vital addition to medical operations.

Consulting Services provided by Strategic Health Resources® include reimbursement analysis and positioning, strategic market and product development, and educational services directed to senior management of technology manufacturers, provider systems and health plans.